- Cardiorenal toxicity of doxorubicin and epirubicin in rats
-
Park YH, Jung HS, Kim WJ, Kwon HS, Kim YT, Moon CO, Park CK, Lee SI, Hong SP
- KMID: 1697971
- Korean J Intern Med.
- 1991 Sep;41(3):392-398.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Antitumor activity of adriamycin and the analogue, THP-adriamycin and epirubicin, against human tumor cell lines
-
Hong WS, Kim CM, Lee MS, Kang YK, Lee CT, Kim YC, Lee JO, Kang TW
- KMID: 1742125
- J Korean Cancer Assoc.
- 1991 Jun;23(2):259-265.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Prophylactic Effect of Intravesical Epirubicin and Bacillus Calmette- Guerin Therapy in Stage T1 Bladder Cancer
-
Kim KJ, Chung JY, Noh CH
- KMID: 2292559
- Korean J Urol.
- 2001 Sep;42(9):919-923.
PURPOSE: We compared the prophylatic effects and complications of intravesical instillation of the epirubicin and Bacillus Calmette-Guerin (BCG) in patients with stage T1 bladder cancer. MATERIALS AND METHODS: A total 87... -
- CITED
-
- Close
- SHARE
-
- Close
- 5-fluorouracil, epirubicin, cisplatin(FEP) and 5-fluorouracil, cisplatin(FP) combination chemotherapy for advanced pancreatic carcinoma
-
Lee KH, Kang WK, Suh CI, Park YS, Kim HT, Kang YK, Kim HJ, Heo DS, Bang YJ, Yoon YB, Kim NK, Park YH
- KMID: 1742132
- J Korean Cancer Assoc.
- 1991 Jun;23(2):315-322.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Intravesical High Dose Epirubicin versus Bacillus Calmette-Guerin Instillation on the Recurrence and Progression of Superficial Bladder Cancer: A Prospective, Multicenter Study
-
Hong SJ, Choi HY, Ahn HJ, Kim CS, Yang WJ
- KMID: 2293983
- Korean J Urol.
- 2005 Jul;46(7):677-682.
PURPOSE: To investigate the effects of intravesical high dose epirubicin instillation, the effect of epirubicin was compared with that of Bacillus Calmette-Guerin (BCG) instillation on the recurrence and progression of... -
- CITED
-
- Close
- SHARE
-
- Close
- miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma
-
Yu L, Meng M, Bao Y, Zhang C, Gao B, Sa R, Luo W
- KMID: 2457479
- Yonsei Med J.
- 2019 Sep;60(9):832-841.
- doi: 10.3349/ymj.2019.60.9.832
PURPOSE: Epirubicin is one of the most effective drugs against osteosarcoma. miR-1301 is involved in the occurrence and development of osteosarcoma. Whether miR-1301 is responsible for the chemosensitivity of osteosarcoma... -
- CITED
-
- Close
- SHARE
-
- Close
- Routine Use of Single Instillation of Epirubicin after Transurethral Resection of Bladder Tumor - Should It Be Done in Korean Patients?
-
Shin YS, Kim MK, Jeong YB, Kim HJ
- KMID: 2411178
- Korean J Urol Oncol.
- 2016 Apr;14(1):39-42.
- doi: 10.0000/kjuo.2016.14.1.39
To study the impact of single instillation of epirubicin (SIE) on the cancer recurrence of non-muscle invasive bladder cancer (NMIBC) after transurethral resection of bladder tumor (TURBT) in Korean patients.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of High Grade Endometrial Stromal Sarcoma Metastatic to the Lung
-
Han DG, Jung SH, Park SC, Kwon OJ, Lee TH, Kim MJ, Koh MW
- KMID: 2272293
- Korean J Obstet Gynecol.
- 2004 Feb;47(2):418-423.
The High grade endometrial stromal sarcoma is very rare. It has occasional local recurrence, which might be arisen from endometrial stroma, from adenomyosis, rarely from endometriosis. We experienced this infrequent... -
- CITED
-
- Close
- SHARE
-
- Close
- Heterogeneous Chemosensitivity of Breast Cancer Determined by Adeonsine Triphosphate Based Chemotherapy Response Assay
-
Choi SK, Jeong J, Lee SA, Hwang SH, Ahn SG, Jung WH, Lee HD
- KMID: 2286544
- J Breast Cancer.
- 2010 Jun;13(2):180-186.
- doi: 10.4048/jbc.2010.13.2.180
PURPOSE: Breast cancer is heterogeneous disease and the response to chemotherapeutic agents is also heterogeneous from patient to patient. Chemotherapy response assay is in vitro test that is performed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful Desensitization to Epirubicin in a Breast Cancer Patient with Doxorubicin Hypersensitivity
-
- KMID: 2234614
- Korean J Asthma Allergy Clin Immunol.
- 2009 Jun;29(2):127-131.
Doxorubicin, a chemotherapeutic agent of the anthracycline family, has commonly been used to treat a wide range of cancers including leukemia, Hodgkin's lymphoma, and cancers of the breast, uterus, ovary... -
- CITED
-
- Close
- SHARE
-
- Close
- The Prognosis of breast Cancr with more than 10 Positive Nodes
-
Chung HJ, Lee YH
- KMID: 2005637
- J Korean Surg Soc.
- 1997 Aug;53(2):185-191.
The status of axillary lymph nodes is the most important prognostic factor of breast cancer. The prognosis of node-positive breast cancer can be further subcategorized based on the number of... -
- CITED
-
- Close
- SHARE
-
- Close
- The Direct Anti-Cancer Effect of a Single Instillation of Epirubicin after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer
-
Shin YS, Kim JY, Ko OS, Doo AR, Kim MK, Jeong YB, Kim HJ
- KMID: 2315565
- Korean J Urol.
- 2012 Feb;53(2):78-81.
PURPOSE: To evaluate the direct anti-cancer effect of a single instillation of epirubicin (SIE) after transurethral resection of bladder tumor (TURBT) for non-muscle-invasive bladder cancer (NMIBC) by analysis of immediate... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Trial of Neoadjuvant Chemotherapy with Genexol(R) (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer
-
Lee J, Kim J, Chang E, Choi W, Lee K, Yoon H, Jung S, Park M, Yoon J, Kim S
- KMID: 2176125
- J Breast Cancer.
- 2014 Dec;17(4):344-349.
- doi: 10.4048/jbc.2014.17.4.344
PURPOSE: Neoadjuvant chemotherapy (NC) is yet to be established as the definitive treatment regimen for locally advanced breast cancer (LABC). The aim of this study was to determine the efficacy... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Chemotherapy of Vinorelbine and Epirubicin ( VE ) in Patients with Advanced Breast Cancer
-
Bang SM, Hong HS, Cha KH, Lee TH, Lee JA, Park YS, Cho EK, Shin DB, Lee JH
- KMID: 2175094
- J Korean Cancer Assoc.
- 2000 Apr;32(2):244-252.
PURPOSE: This study was performed to evaluate the efficacy and toxicity of vinorelbine in combination with epirubicin as a first-line chemotherapy in patients with advanced breast cancer as well as a second-line... -
- CITED
-
- Close
- SHARE
-
- Close
- Multidrug resistance and cytotoxicity of anticancer drug by verapamil in cisplatin resistant human stomach cancer cell
-
Son SK, Kim JH
- KMID: 2377606
- Yeungnam Univ J Med.
- 1992 Jun;9(1):75-89.
- doi: 10.12701/yujm.1992.9.1.75
The development of multidrug-resistant tumor cell population is a major problem in the chemotherapy of human cancer. These cells are often cross resistant to unrelated drugs and the precise mechanisms... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Bilateral Retroorbital Non-Hodgkin's Lymphoma
-
Lee JM, Lee SK, Kim KW, Seo JW, Lee EJ, Lee EH, Park SY
- KMID: 2305234
- Korean J Hematol.
- 1998 Aug;33(2):262-267.
Retroorbtal lymphoma is a rare disease. It is reported to be an indolent, usually stage I disease, showing low to intermediate-grade histology with good response to radiation without adjuvant chemotherapy.... -
- CITED
-
- Close
- SHARE
-
- Close
- A Phase II Study of Ifosfamide, Carboplatin, and Epirubicin (ICE) Combination Chemotherapy for Extensive Disease of Small Cell Lung Cancer
-
Byun JH, Woo IS, Song HH, Lee KS, Ahn JS, Jang DY, Lee JA, Park YL, Park YS
- KMID: 1568909
- Cancer Res Treat.
- 2002 Dec;34(6):416-420.
PURPOSE: To evaluate the efficacy and safety of ifosfamide, carboplatin and epirubicin (ICE) combination chemotherapy for extensive disease small cell lung cancer (SCLC) patients, who had received no previous chemotherapy,... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Epirubicin, Cisplatin, oral UFT, and Leucovorin Combination Chemotherapy in Advanced Stomach Cancer
-
Yoon SY, Seo JH, Choi CW, Kim BS, Mok YJ, Kim CS, Chun HJ, Hyun JH, Kim YH, Kim JS
- KMID: 2306289
- Korean J Med.
- 1999 Jun;56(6):730-737.
OBJECTIVE: UFT plus leucovorin treatment had favorable activity and tolerable toxicity in patients with advanced stomach cancer. Recently, high response rates have been reported in patients with advanced stomach cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Cispatin , Etoposide , Leucovorin and 5-Fluorouracil ( PELF ) Combination Chemotherapy for Advanced Gastric cancer: Interim Report
-
Park IR, Kim SY, Kim JH, Yoon HJ, Cho KS
- KMID: 2175331
- J Korean Cancer Assoc.
- 1998 Oct;30(5):907-913.
PURPOSE: In attempt to provide a feasible chemotherapeutic regimen for advanced gastric cancer patients, the combination of cisplatin, epirubicin, leucovorin and fluorouracil (PELF) has been developed. A trial was performed... -
- CITED
-
- Close
- SHARE
-
- Close
- Randomized Phase III Trial of Cisplatin, Epirubicin, Leucovorin, 5-Fluorouracil (PELF) Combination versus 5-fluorouracil Alone as Adjuvant Chemotherapy in Curative Resected Stage III Gastric Cancer
-
Lee JJ, Kim SY, Shin I, Cho KS, Joo HZ, Yoon C, Kim YW, Yoon HJ
- KMID: 2127914
- Cancer Res Treat.
- 2004 Apr;36(2):140-145.
PURPOSE: The combination of cisplatin, epirubicin, leucovorin and 5-fluorouracil (PELF) administration, as adjuvant chemotherapy after curative resection for gastirc cancer, was compared with 5-fluorouracil (5-FU) administration alone. This paper reports... -
- CITED
-
- Close
- SHARE
-
- Close
